Multidisciplinary Approach and Technology Integration Show Promise for Addressing Hidradenitis Suppurativa Care Disparities
核心洞察
Hidradenitis suppurativa (搜索) disproportionately affects women at a 3:1 ratio and shows significantly higher prevalence in African American populations with more severe disease progression.
Patients in rural areas and under-resourced communities face substantial barriers including lack of specialist access, transportation issues, and insurance challenges that delay diagnosis and treatment.
Clinical pharmacists and technology integration through AI-based alerts and electronic medical record screening tools can bridge care gaps and improve early detection across diverse healthcare settings.
Significant disparities in hidradenitis suppurativa (搜索) (HS (搜索)) diagnosis and management are creating substantial barriers to care, with new research highlighting how multidisciplinary approaches and technology integration could address these critical gaps. The chronic inflammatory skin condition affects patients unequally across demographic lines, with healthcare access heavily influenced by race, gender, geography, and socioeconomic status.
Gender and Racial Disparities Drive Unequal Disease Burden
HS (搜索) demonstrates a pronounced gender disparity, affecting women at approximately a 3:1 ratio compared to men, particularly in early and moderate disease stages. However, the condition appears to progress more severely in male patients, which narrows the gender gap over time as the disease advances.
Racial disparities present an even more concerning pattern. African American individuals experience significantly higher prevalence rates and often face more severe disease progression compared to other populations. These disparities are compounded by cultural factors, including mistrust of the healthcare system and generational normalization of symptoms, where recurrent boils are often viewed as hereditary or inevitable rather than treatable medical conditions.
Geographic and Economic Barriers Create Treatment Delays
Access to appropriate care varies dramatically based on location and economic resources. Patients in urban areas with specialist access are far more likely to receive early diagnosis and effective treatment, while those in rural or under-resourced communities encounter significant obstacles including lack of transportation, limited specialist availability, and insurance challenges.
Financial constraints particularly affect individuals on Medicaid or those who are uninsured, who frequently delay seeking care due to cost concerns or difficulty navigating the healthcare system. For many immigrant families and people of color, fear of medical costs prevents timely evaluation and treatment, contributing to prolonged suffering and delayed access to effective interventions.
Technology and Multidisciplinary Care Offer Solutions
Healthcare systems are exploring innovative approaches to bridge these care gaps through technology integration and expanded provider networks. Clinical decision support systems embedded in electronic medical records can implement validated screening tools and AI-based alerts to flag at-risk patients, particularly those with recurrent abscesses or frequent antibiotic use.
This technological integration promotes health equity by ensuring screening capabilities are available in both large academic centers and smaller, resource-limited clinics. Through standardized tools and pathways, providers without HS (搜索) expertise can apply best practices to identify and refer patients efficiently, reducing diagnostic delays.
Pharmacists Emerge as Key Care Coordinators
Clinical and community pharmacists are uniquely positioned to address existing care gaps in HS (搜索) management. Embedded clinical pharmacists in specialty clinics can identify patients with recurring antibiotic prescriptions or frequent infections that suggest undiagnosed HS. Their expanded role includes guiding appropriate treatment selection while considering patient comorbidities and insurance coverage, and ensuring timely access to biologics (搜索) or other advanced therapies.
Community pharmacists serve as accessible first points of contact and can refer patients to appropriate providers when over-the-counter treatments prove ineffective. This positioning allows them to serve as trusted intermediaries, particularly important for historically marginalized populations who may have limited healthcare system engagement.
Comprehensive Provider Education Essential
Given that HS (搜索) patients present across various care settings—from primary care and adolescent medicine to emergency departments and wound care clinics—education across all healthcare specialties is vital. Surgeons, dermatologists, gynecologists, mental health professionals, and social workers all encounter these patients, making broad-based awareness campaigns and continuing education critical for improving early detection.
The multidisciplinary approach creates a more coordinated, patient-centered care model that improves time to diagnosis, treatment personalization, and overall disease control. Community engagement through trusted healthcare providers can help dispel misconceptions about the disease while emphasizing that HS (搜索) is treatable rather than something patients must endure.
These coordinated efforts to expand access through telehealth, patient assistance programs, and culturally competent education represent promising strategies for addressing longstanding disparities in HS (搜索) care. Early medical intervention not only benefits individual patients but can create positive ripple effects through families and communities, improving awareness, early detection, and health outcomes across generations.